The 20 Best Oligodendroglioma Doctors Near Me in Vienna, 9

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is rated as a Distinguished provider by MediFind in the treatment of Oligodendroglioma. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy. Dr. Sahebjam is board certified in American Board Of Internal Medicine.

Joseph Watson is a Neurosurgery provider practicing medicine in Vienna, Virginia. Dr. Watson is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Meningioma, Chronic Subdural Hematoma, Awake Craniotomy, and Gastrostomy.

Brownstein Chair, Brain Tumor Research Co-Director, Neuro-Oncology, Inova Schar CancerDr. Adam L. Cohen is a specialty care physician board certified in neuro-oncology, medical oncology and internal medicine. He received his MS from the University of Chicago and MD from Harvard. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Embryonal Tumor with Multilayered Rosettes, Glioblastoma, Neuroepithelioma, Bone Marrow Aspiration, and Liver Embolization.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as a Distinguished provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Mark Goldstein is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Goldstein is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Goldstein is board certified in American Board Of Internal Medicine.

Buelent Yapicilar is a Neurosurgery provider practicing medicine in Vienna, Virginia. Dr. Yapicilar is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Chronic Subdural Hematoma, Stroke, Awake Craniotomy, and Gastrostomy.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery. Dr. Page is board certified in American Board Of Radiology.

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy. Dr. Ross is board certified in American Board Of Psychiatry And Neurology.

Dr. Comair is an internationally recognized neurosurgeon and sees patients for a wide range of neurosurgical needs. He offers surgical therapy for diseases of the brain and spine and has pioneered awake craniotomies for the resection of intrinsic brain tumors. His surgical expertise also includes epilepsy surgery, deep brain stimulation for Parkinson’s disease and essential tremor, trigeminal neuralgia surgery, radiosurgery, and treatment for hydrocephalus and herniated disc repair. Dr. Comair received his medical degree from St. Joseph University in Beirut, Lebanon, and completed his neurosurgery residency at Montreal Neurological Institute, McGill University. He completed fellowship training in brain tumor and functional neurosurgery at Montreal Neurological Institute. He has held adjunct faculty appointments at Baylor College of Medicine in Houston, Texas, and the Johns Hopkins University School of Medicine. Dr. Comair has educated scores of neurosurgical trainees in the Middle East, North Africa region, and the U.S., authored more than 120 publications in peer-reviewed journals and two leading textbooks of neurosurgery. He contributed chapters to more than 40 textbooks. Dr. Comair has received multiple awards and recognitions and has been an invited visiting professor to the most prestigious neurosurgery centers. He is a diplomate of the American Board of Neurosurgery and a fellow of the royal college of surgeons of Canada. He serves on the board of directors of the World Society of Functional and Stereotactic Neurosurgery and has been elected to the pediatric epilepsy surgery committee of the International League Against Epilepsy (ILAE). Dr. Comair has held several prominent academic and clinical positions throughout his career, including assistant professor of neurosurgery and head of the pediatric epilepsy surgery section in the Department of Neurosurgery at the UCLA School of Medicine; attending neurosurgeon and head of the section of epilepsy surgery in the Department of Neurosurgery for the Cleveland Clinic Foundation; professor and chair of the Division of Neurosurgery at the American University of Beirut in Lebanon; and professor and vice-chair of the Department of Neurosurgery at Baylor College of Medicine in Houston, Texas. Dr. Comair is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. His clinical expertise encompasses Brain Tumor, Glioma, Oligodendroglioma, Trigeminal Neuralgia, and Awake Craniotomy. Dr. Comair is board certified in American Board Of Neurological Surgery and Royal College Of Physicians And Surgeons Of Canada.

Shih-Chun (David) Lin, M.D., is a neurosurgeon with Johns Hopkins Neurosurgery in Bethesda, Maryland, as well as an associate professor in the Department of Neurosurgery at the Johns Hopkins University School of Medicine. Dr. Lin offers neurosurgical care to patients with brain or spine diseases. He was the first to introduce several procedures to Suburban Hospital, including endoscopic pituitary surgery, endoscopic extended skull base surgery, minimally invasive spine surgery, neurosurgical complex spinal instrumentation surgery, stereotactic radiosurgery and microvascular decompression for cranial nerve compression syndrome, such as trigeminal neuralgia. He also has clinical expertise in MRI- and CT-guided surgical navigation. Dr. Lin typically treats brain tumors, spinal tumors, pituitary tumors, spinal stenosis, herniated intervertebral disc, skull base tumors, encephalocele, and skull base CSF leak (rhinorrhea or otorrhea). Dr. Lin graduated first place from National Taiwan University College of Medicine, earning his medical degree at the age of 21, the youngest in Taiwan’s history. He then served as a medical/surgical officer in the 206th Infantry Division for the Taiwan Army. He received his Ph.D. in neuroscience from Johns Hopkins University, awarded Phi Beta Kappa and Paul Ehrlich Research Award for his academic and research achievements. Dr. Lin completed his neurosurgical residency at Stanford University Medical Center, where he gained experience in the latest surgical technologies, such as endoscopic surgery, minimally invasive surgery, computer-guided surgical navigation and stereotactic radiosurgery. His research using optogenetics, from his fellowship at Stanford, was awarded by The Congress of Neurological Surgeons. Dr. Lin is a member of the Suburban Hospital Tumor Board. He has worked on several system innovation and quality improvement efforts at Suburban Hospital, such as standardizing critical care protocols for post-operative care for patients undergoing pituitary surgery and establishing MRI protocols for patients implanted with spinal cord stimulators or cardiac pacemakers. Dr. Lin is also a fellow of the American Association of Neurological Surgeons and a member of the Congress of Neurological Surgeons. Dr. Lin has earned numerous awards, such as the Teaching Excellence Award for Stanford University School of Medicine, the Service Excellence Award for Suburban Hospital, Best Consulting Physicians at Johns Hopkins Medicine, Surgeon of the Year Award at Suburban Hospital, and was named one of America's Top Surgeons for Consumers' Research Council of America, Washingtonian Top Doctors, and Bethesda Magazine Top Doctors. Dr. Lin's research interests are in optogenetics, investigating mechanisms behind epilepsy control and glial cell reaction to pathologic conditions. He has contributed to numerous publications and lectures. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Binder's Syndrome, Frontonasal Dysplasia, Craniectomy, and Awake Craniotomy. Dr. Lin is board certified in American Board Of Neurological Surgery.

Julie Oda is a Hematologist and an Internal Medicine provider practicing medicine in Mclean, Virginia. Dr. Oda is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Idiopathic Neutropenia, Iron Deficiency Anemia, and Paget Disease of the Breast.

Iva Ferreira is a Hematologist and an Oncologist practicing medicine in Mclean, Virginia. She has been practicing medicine for over 18 years. Dr. Ferreira is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. Her clinical expertise encompasses Angiosarcoma, Pseudomyxoma Peritonei, Paget Disease of the Breast, and Metastatic Brain Tumor.

Dr. Kevin Choe is a specialty care physician board certified in radiation oncology at Inova Health System. He joined Inova in 2015 and has been practicing since 2005. Prior to joining Inova, Dr. Choe was on the faculty at University of Texas, Southwestern Medical Center in Dallas, TX, where he specialized in high-precision stereotactic radiotherapy. His research focused on elucidating the genetic alterations that contribute to cancer development and progression. He also designed and conducted clinical trials, investigating novel strategies to overcome treatment resistance in aggressive and metastatic cancers. Dr. Choe grew up in Fairfax, VA, and appreciates the opportunity to serve the community he cares deeply for. Dr. Choe is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.

Dr. Mateo Ziu is board certified in neurological surgery. He joined Inova Medical Group with more than 12 years of clinical experience and serves as the medical director of Inova Brain and Spine Tumor Program and medical director of neuro-oncology at Inova Schar Cancer Institute. He has completed a fellowship and gained advance training in the surgical management of brain, spine and pituitary tumors. He has a keen interest in the delivery of multidisciplinary evidence-based care for patients with benign and malignant nervous system tumors. He collaborates with world-wide clinical investigators in multiple clinical trials for patients with these tumors. Before joining Inova Medical Group Neurosurgery, Dr. Ziu practiced in Austin, TX where he was the Medical Director of the Brain and Spine Tumor Program and Pituitary Care Center of Seton Brain and Spine Institute. He was an Assistant Professor at the Dell. Dr. Ziu is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Glioblastoma, Astrocytoma, Awake Craniotomy, and Laminectomy.

Dr. Lonika Majithia is currently the Medical Director of Brachytherapy and Director of Educational Programs at Radiation Oncology Associates, and is board certified in radiation oncology. She joined Radiation Oncology Associates in 2016. Her clinical interests include gynecologic, breast, CNS, GI, thoracic and hematologic malignancies. Dr. Majithia is experienced with multiple radiotherapy techniques including volumetric modulated arc therapies (VMAT), intensity modulated radiation therapy (IMRT), stereotactic body radiotherapy, Gamma Knife and CyberKnife Radiosurgery, intra-operative radiotherapy (IORT), eye plaque brachytherapy, and prostate and gynecologic brachytherapy, including High Dose Rate (HDR) brachytherapy. Dr. Majithia grew up in Albuquerque, NM. She graduated magna cum laude from the University of New Mexico with dual bachelor’s degrees in biology and physics. She was awarded the UNM Merit Scholarship and actively participated in physics and basic science research. She completed her medical training at the University of New Mexico where she was elected to the Alpha Omega Alpha Medical Honor Society. She completed her preliminary medicine internship at the Medical College of Wisconsin in Milwaukee, WI and her radiation oncology residency at The Ohio State University in Columbus, OH. She served as Chief Resident during her last year of residency and remained active in academic pursuits including research and medical education. During her residency, she presented multiple abstracts and presentations at the American Society for Radiation Oncology (ASTRO) annual meetings and American Society of Clinical Oncology (ASCO) meetings. She has published book chapters, written retrospective review articles, and assisted in the development of a phase I clinical trial in hematologic malignancies. During her residency, she also completed a master’s degree in medical sciences. Dr. Majithia is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Metastatic Brain Tumor, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer.

Dr. Daniel Kim is a specialty care physician board certified in radiation oncology at Inova Health System. Dr. Kim graduated top of his class from Amherst College with degrees in neuroscience and music, while becoming a four-time All-American tennis athlete and winning the NCAA men’s tennis championship. He graduated with his MD and MBA, with honors, from Harvard. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Meningioma, and Prostatectomy.

Dr. Sarah Gao is a specialty care physician board eligible in radiation oncology. She joined Radiation Oncology Associates in 2022. Dr. Gao is trained in all aspects of radiation oncology, and her practice focuses on the treatment of all types of cancers with an additional focus on the treatment of breast, gynecological, and head and neck malignancies. Dr. Gao grew up in California and attended California State University in Los Angeles through the early entrance program, graduating magna cum laude with a degree in biochemistry. She went on to receive her medical degree from Yale School of Medicine in New Haven, CT, where she was a recipient of the Hirsch and Hsiung Fellowship for medical research. She completed her radiation oncology residency at Yale and served as chief resident. Dr. Gao has experience across a variety of treatment modalities including intensity-modulated radiation therapy, volumetric modulated arc therapy, stereotactic body radiotherapy, Gamma Knife radiosurgery, gynecologic brachytherapy, total skin electron therapy and orthovoltage therapy. During her training, Dr. Gao’s research endeavors focused on using data science to further personalize the treatment of cancer patients. She has experience creating and managing clinical databases, performing advanced statistical analyses, and building supervised machine learning models. She has given multiple oral presentations at national meetings and has authored numerous peer-reviewed publications, book chapters and editorials. Dr. Gao sees patients at Inova Schar Cancer Institute in Fairfax, VA, and at Potomac Radiation Oncology in Woodbridge, VA. Outside the clinic, Dr. Gao enjoys reading, listening to music, trying new recipes and spending time with family. Dr. Gao is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Metastatic Brain Tumor, Prostate Cancer, Familial Prostate Cancer, and Lymphadenectomy.

Mather Chair, Radiation Oncology Department Chair and System Division Chief, Inova Radiation Oncology Inova Schar CancerDr. Ashish Chawla is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2011.He received his undergraduate degree from Pennsylvania State University, graduating with honors in biology. He received his medical degree from Thomas Jefferson University in Philadelphia in 1998, where he was elected to the prestigious Alpha Omega Alpha Medical Honor Society. He completed his radiation oncology training at Harvard’s Massachusetts General Hospital in 2003. There, he won awards for scholarly research as a radiation oncology resident. He has published several peer-reviewed articles related to breast, prostate and gastrointestinal cancer management.Prior to joining Radiation Oncology Associates, he served as a radiation oncologist at Anne Arundel Medical Center in Annapolis, MD. There, he helped lead innovative clinical research as the principal investigator for breast cancer protocols with the Radiation Therapy Oncology Group. He also helped lead the cancer center’s stereotactic radiosurgery program and served as cancer liaison for the American College of Surgeons’ Commission on Cancer. He led numerous studies involving partial breast irradiation as well as prostate, central nervous system, and head and neck cancer investigations.Dr. Chawla’s clinical interests include the multidisciplinary management of breast cancer and prostate cancer patients, and he is the Director of the Partial Breast Irradiation Program at Inova Fairfax Hospital. He has expertise in the use of stereotactic radiosurgery and stereotactic body radiotherapy for tumors of the brain, spine and lung. Additional areas of clinical interest include gastrointestinal, lung, head and neck, and brain tumors.Dr. Chawla has been listed in Washingtonian magazine, Northern Virginia Magazine, and U.S. News and World Report as “Top Doctor” for radiation oncology in the Washington, DC, and Northern Virginia areas. Dr. Chawla is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Prostate Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.

Mather Director, Radiation Oncology Research Inova Radiation Oncology Inova Schar CancerDr. Avani Rao is a specialty care physician board certified in radiation oncology who serves as the Director of Research, Proton Therapy Fellowship Director and lead physician in pediatric radiation oncology. She joined Radiation Oncology Associates in 2020. Her areas of interest are pediatric, gynecologic, gastrointestinal and breast malignancies.Dr. Rao graduated from Yale University magna cum laude with a bachelor’s degree in molecular, cellular and developmental biology. She completed medical school, her internal medicine internship and her radiation oncology residency at Johns Hopkins School of Medicine. She was nominated to Alpha Omega Alpha during medical school, and during her residency, Dr. Rao served as Chief Resident. She pursued additional fellowship training at the University of Maryland to gain specific expertise in proton therapy. Dr. Rao has received several awards supporting her research and recognizing her clinical excellence and has published more than 40 peer-reviewed publications. Dr. Rao is board certified in radiation oncology. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Dr. C. Bryce Johnson is a specialty care physician board certified in radiation oncology. He joined Inova Health System in 2021 and has been practicing since 2017. Prior to joining Inova, Dr. Johnson completed his radiation oncology residency at Memorial Sloan Kettering Cancer Center. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Metastatic Brain Tumor, Pleuropulmonary Blastoma, and Familial Prostate Cancer.